Back to search
Philadelphia Negative Myeloproliferative Neoplasms
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Philadelphia Negative Myeloproliferative Neoplasms trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Philadelphia Negative Myeloproliferative Neoplasms trials you may qualify forWe hypothesize that pacritinib leads to modification of the myelofibrosis (MF) disease phenotype, especially related to BM fibrosis and cytopenias; due potentia…
This phase II trial compares the effect of ASTX727 in combination with iadademstat to ASTX727 alone in treating patients with accelerated or blast phase Philade…
This study will ultimately aim at developing a GIMEMA platform for collecting HRQoL and symptom burden information on Italian patients with Philadelphia chromos…
This study assesses the potential of using a TGFβ receptor inhibitor for the treatment of anemic patients with myeloproliferative neoplasms. TGFβ signaling is k…